[{"id":"fa6223ae-78f2-443c-a255-1f06c8ef7cf8","acronym":"","url":"https://clinicaltrials.gov/study/NCT05831995","created_at":"2023-04-27T14:04:51.130Z","updated_at":"2024-07-02T16:35:23.994Z","phase":"Phase 1","brief_title":"Safety and Effectiveness of ABM-168 in Adults With Advanced Solid Tumors.","source_id_and_acronym":"NCT05831995","lead_sponsor":"ABM Therapeutics Corporation","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ABM-168"],"overall_status":"Recruiting","enrollment":" Enrollment 112","initiation":"Initiation: 03/30/2023","start_date":" 03/30/2023","primary_txt":" Primary completion: 10/16/2025","primary_completion_date":" 10/16/2025","study_txt":" Completion: 10/16/2025","study_completion_date":" 10/16/2025","last_update_posted":"2024-01-10"}]